When my father died from cancer a few months ago, I had a lifetime to regret that I did not become a doctor. That said, I could hardly have helped him a great deal, I think, given the limitations we had then in cancer treatment. Luckily for all of us, aspirin cancer treatments are being studied right now.

According to recent medical findings and based on a body of evidence, the cheap and often overlooked aspirin can help prevent cancer and reduce the risk of dying from it. Since this medicament is so cheap and widely distributed, the research was welcomed by medical experts all over the globe. Had this only been common knowledge at the time that we discovered my dad’s illness, we might have spared him some of the pain.

That having been noted, it must be mentioned too that the drug is not able to remove cancer and can only help you avoid its onset. In the research, it was discovered that aspirin doses on a controlled but fairly often-taken form were linked in some way to the reduction of cancer possibilities. For those who are already inflicted, aspirin can slow down metastasis.

According to the researchers, one cancer may react quite variably from another when exposed to the substance. The studies revealed that the rate of effectiviness seemed to vary, with common kinds like those affecting the lungs and colon to be most effectively prevented. My own parent died of colon cancer.

Meanwhile, a research study led by Oxford professor Dr. Peter M. Rothwell observed that the risk of esophageal cancer was reduced by a staggering 75% and of the common colorectal cancer by 40-50%. This could indicate that you should begin to consider the idea of aspirin as a controlled medicament for helping you fight a history of cancer in your bloodline. With such developments, a few doctors, medical experts and researchers are almost ready to proclaim that taking aspirin for cancer works, but it is not without harmful side effects.

Untrammelled use of aspirin could well result to negative consequences, of course. Aspirin in untrammelled dosages has been shown to raise the chances of things such as stroke caused by hemmorhage. Needless to say, both bleeding and stroke can kill, which means taking too much aspirin will do more harm than good.

There are yet those in healthcare who say they will not make recommendations about taking the substance just yet. There exist some scientists who claim no connection between aspirin and the development/hindrance of cancerous cells. Since these studies did not administer aspirin every day to the subjects, however, they are considered suspect.

Still, experts question the integrity of the Oxford studies since those were originally conducted to study the effects of aspirin on heart diseases. In the US, it is common for physicians to recommend daily doses of baby aspirin for cases involving cardiac risk. Critics note that cardiac problems are quite different from cancer-related ones.

A qualified stance is perhaps the best one in this matter, as with many other yet-experimental notes in medicine. For example, one of the heads of the American Cancer Society has spoken out in favor of more research, though not necessarily aspirin consumption. The general idea, as a Harvard-based professional noted, is that the research is meant to stimulate more research that can give us a final answer as to whether or not it can really help us.

Their learning obviously far surpasses mine here, so I cannot question them in the details. That said, I feel the absence of my own cancer-stricken relative keenly enough to be eager about anything that could bring down the possibility of cancer for others. I hope that with time and more research on aspirin cancer will become less common.

It has been known that untrammeled dosages of aspirin would result to various conplications like gastrointestinal bleeding and hemorrhagic strokes.